On May 20, 2025, Biodesix Inc. held its annual stockholder meeting where shareholders elected two directors, ratified KPMG as the independent auditor, approved a reverse stock split, and increased shares in the employee stock plan by 1.45 million. In total, 146.4 million shares were eligible to vote.